
Italian World Scleroderma Foundation
@italianwsf
La Fondazione, con sede in Italia, non ha fini di lucro, persegue esclusivamente finalità civiche, solidaristiche e di utilità sociale mediante lo svolgimento i
ID: 1663270338333925376
http://worldsclerofound.it 29-05-2023 19:46:20
44 Tweet
17 Followers
14 Following

Andrea | Self-knowledge Mentor 🌞
@andreaolivov
Boosting self-knowledge in all people ♿️🏋🏻♀🏳🌈
Annals of the Rheumatic Diseases
@eular_ard
Annals of the Rheumatic Diseases (#1 research journal in Rheumatology). High quality, peer reviewed research.
Agenzia ANSA
@agenzia_ansa
Le top news dell’ANSA, la più importante agenzia d’informazione in Italia. Ultim’ora, notizie, foto e video da tutto il mondo. Aggiornamenti 24 ore su 24. #ANSA
allanore yannick
@allanore
Rheumatologist at Cochin Hospital (head of rheumatology department) and researcher at Cochin Institute with special interest in systemic sclerosis
Maria Grazia Lazzaroni
@lazzaronim
MD Rheumatologist @ Spedali Civili Brescia | PhD @unibs_official | EUSTAR Board_Counsellor @EUSTAR_org | Fellow @ern_reconnet #SystemicSclerosis
Cosimo Bruni
@cosimobruni

carla garbagnati
@carlagarbagnati
Saper ascoltare
GILS
@gils_odv
Gruppo Italiano Lotta alla Sclerodermia
Raffaella Gallo
@raffaellagallo_
Cell biologist. @Fondaz_Veronesi Postdoctoral Fellow at UMG, Catanzaro 🇮🇹 - PhD from @pelkmanslab , University of Zurich🇨🇭
alison
@alisonzheng24

Corrado Campochiaro
@campochiarocor
Rheumatology and Clinical Immunology
Dr. Dinesh Khanna
@sclerodermaum
👉University of Michigan Scleroderma Program leading the way through excellence in clinical care, teaching, & research #scleroderma tweets≠advice Follow≠endorse
EUSTAR
@eustar_org
European Scleroderma Trials and Research group - aims to foster the awareness, understanding and research of scleroderma and its management throughout Europe
World Scleroderma Foundation
@worldsclerofnd
The World Scleroderma Foundation is a non-profit, non-governmental foundation based in Switzerland, promoting scleroderma research and supporting patients.